Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01520337

Enrollment

170

Registered

2012-01-27

Start date

2012-01-31

Completion date

2013-10-31

Last updated

2014-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polyp and Adenoma Detection During Colonoscopy

Brief summary

Polyp detection rate in colonoscopy following oral administration of MMX methylene blue tablets

Detailed description

Polyp detection rate in colonoscopy following oral administration of methylene blue MMX modified release tablets in subjects undergoing colonoscopy as outpatients.

Interventions

DEVICEoral tablet dye for detection of polyps during colonoscopy

oral tablet dye for improved detection of

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients scheduled for screening or surveillance colonoscopy. Written informed consent.Practising reliable contraception or sterile.Ability to understand and comply with the protocol.

Exclusion criteria

* Pregnancy or lactation known or suspected hypersensitivity GI obstruction or perforation serious cardiovascular, renal or hepatic disease. reduced prothrombin time,elevated serum creatinine.

Design outcomes

Primary

Measure	Time frame
Polyp and adenoma detection rate	1 day

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026